Infanrix hexa, susp inj 0.5 ml (ancien), ser prê 1 dos

7680006400016 CH-640 J07CA09
Infanrix hexa, susp inj 0.5 ml (ancien), ser prê 1 dos
Infanrix hexa, susp inj 0.5 ml (ancien), ser prê 1 dos
Infanrix hexa, susp inj 0.5 ml (ancien), ser prê 1 dos
1 / 3
google

Details

Product number
-
CPT
-
Packaging group
-
Unit
-

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
27/06/2025
Professional SmPC
Français
27/06/2025
Professional SmPC
Italien
27/06/2025

Detailed composition

Substance Quantity Type Category
II
10.0 UG Substance Wirkstoff (Principe actif)
12C
- Substance Wirkstoff (Principe actif)
I
- Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
I
- Substance Wirkstoff (Principe actif)
12C
- Substance Wirkstoff (Principe actif)
I
25.0 UG Substance Wirkstoff (Principe actif)
II
0.12 MG Substance HBESI
12C
25.0 UG Substance Wirkstoff (Principe actif)
12C
25.0 UG Substance Wirkstoff (Principe actif)
I
25.0 UG Substance Wirkstoff (Principe actif)
II
- Substance HNIDK
12C
8.0 UG Substance Wirkstoff (Principe actif)
I
8.0 UG Substance Wirkstoff (Principe actif)
I
40.0 UI Substance Wirkstoff (Principe actif)
12C
40.0 UI Substance Wirkstoff (Principe actif)
I
8.0 UI Substance Wirkstoff (Principe actif)
12C
8.0 UI Substance Wirkstoff (Principe actif)
I
32.0 UI Substance Wirkstoff (Principe actif)
12C
32.0 UI Substance Wirkstoff (Principe actif)
I
10.0 UG Substance Wirkstoff (Principe actif)
12C
10.0 UG Substance Wirkstoff (Principe actif)
12C
10.0 UG Substance Wirkstoff (Principe actif)
I
0.5 MG Substance HBESI
I
- Substance HNIDK
12C
0.5 MG Substance HBESI
12C
- Substance HNIDK
I
0.2 MG Substance HBESI
I
- Substance HNIDK
12C
0.32 MG Substance HBESI
I
- Substance HNIDK
12C
- Substance HNIDK
I
1.8 MG Substance HBESI
12C
- Substance HNIDK
I
- Substance HNIDK
12C
1.8 MG Substance HBESI
I
- Substance HNIDK
12C
- Substance HNIDK
12C
- Substance HNIDK
12C
- Substance HNIDK
I
- Substance RESI
I
- Substance RESI
I
- Substance RESI
12C
- Substance RESI
12C
- Substance RESI
I
- Substance RESI
12C
- Substance RESI
I
- Substance RESI
12C
- Substance RESI
12C
- Substance RESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
640
Drug name
Infanrix hexa, Pulver und Suspension zur Herstellung einer Injektionssuspension
Galenic form
PULSIN
ATC Code
J07CA09
Authorization status
Z
Dispensation category
B
First authorization
02/10/2000
Authorization expiration date
31/12/9999
IT number
08.08.
Domain
Human medicine
Field of application
Grundimmunisierung und Auffrischimpfung, gegen Diphtherie, Tetanus, Pertussis, Hepatitis B, Poliomyelitis und Haemophilus influenzae Typ b, ab der vollendeten 6. Lebenswoche

Packaging details

Description (FR)
INFANRIX hexa susp inj ser pré 0.5 ml
Description (DE)
INFANRIX hexa Inj Susp Fertspr 0.5 ml
Narcotic (BTM)
No

Application methods

IMU

Other packaging sizes

INFANRIX hexa susp inj (n ser pré) 0.5 ml
1 x 1 KOMB
GTIN: 7680006400030
View
INFANRIX hexa susp inj (n ser pré) 10 x 0.5 ml
10 x 1 KOMB
GTIN: 7680006400047
View